查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363144

重症监护诊断市场规模、份额、趋势分析报告：按类型、最终用途、地区、细分市场趋势，2023-2030 年

Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency Rooms, Intensive Care Units), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 85 Pages | 商品交期: 2-10个工作天内

价格

重症监护诊断市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球重症监护诊断市场预计将达到 17.2 亿美元。

预计2023年至2030年该市场将以4.9%的年复合成长率成长。支持该行业增长的关键要素是医生和患者对这些测试的认识和认可迅速提高、老年人口和慢性疾病数量的增加、偏远地区远端医疗服务的采用以及技术的进步。 。分子诊断成本上升和技术纯熟劳工短缺预计将成为限制该行业成长的要素。

依类型细分重症监护诊断市场，分为常规化学、特种化学、流式细胞仪、血液学、免疫蛋白、微生物学/感染疾病、血液凝固检验等。预计微生物和传染病检查和诊断领域的成长率最高，在预测期内年复合成长率将超过 5.5%。例如，医疗保健系统花费大量资源收集和处理血液培养物以进行病原体鉴定。

重症监护诊断测试（例如核酸增幅检查）使临床医生能够更快、更准确地检测和鉴定细菌，尽快启动适当的抗菌治疗并消除可避免的药物使用。为希望停止使用的临床医生提供指南。重症监护诊断市场依最终用途分为手术室、急诊室和 ICU。在预测期内，急诊室领域的成长率预计最高。

重症监护诊断市场报告亮点

  • 预计亚太地区在预测期内将以 6.9% 的年复合成长率增长最快。老年人口众多、慢性病患病不断上升、亚太地区专科医院数量不断增加以及农村地区医疗服务和基础设施的改善是推动市场成长的要素。
  • 按类型分類的危重诊断市场份额来看，免疫蛋白诊断检测领域预计将占据最大份额。对快速、准确的预防性医疗服务的需求不断增长是推动该市场成长的主要要素之一。
  • 截至最终用途，约 20% 的急诊护理患者入住 ICU，约 58% 入住急诊室。预计急诊室在预测期内将以最高年复合成长率呈指数级增长。最近病患对急诊服务的需求增加是由于急诊室有能力为重症患者提供初步的急性护理诊断和治疗。

目录

第1章调查方法和范围

第2章执行摘要

第3章重症监护诊断市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 重症监护诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章重症监护诊断：类型估计/趋势分析

  • 重症监护诊断市场：要点
  • 重症监护诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 常规和特种化学
  • 流式细胞仪
  • 血液学
  • 免疫蛋白
  • 微生物与感染疾病
  • 血液凝固检验
  • 其他的

第5章重症监护诊断：按最终用途的估计和趋势分析

  • 重症监护诊断市场：要点
  • 重症监护诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 手术室
  • 加护病房
  • 急诊室
  • 其他的

第6章重症监护诊断市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的重症监护诊断市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • BD
    • EKF Diagnostics
    • bioMerieux, Inc.
    • Siemens Healthcare Private Limited
    • Chembio Diagnostics, Inc.
    • Bayer AG
Product Code: GVR-1-68038-010-1

Critical Care Diagnostics Market Growth & Trends:

The global critical care diagnostics market size is expected to reach USD 1.72 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to grow at a CAGR of 4.9% from 2023 to 2030. The key factors supporting the industry's growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in geriatric population and chronic health conditions, the employment of telehealth services in remote areas, and technological advancements. The increased cost of the molecular diagnostics and dearth of skilled labor are factors that are expected to hinder the growth of the industry.

The critical care diagnostics market by type is categorized into routine and special chemistry, flow cytometry, hematology, immunoproteins, microbial and infectious diseases, coagulation testing, and others. The microbial and infectious diseases test diagnostics segment is projected to grow at the highest rate with a CAGR of over 5.5% during the forecast period. For example, healthcare systems spend a substantial amount of resources in the collection and processing of blood cultures for the identification of pathogens.

Critical care diagnostic tests, such as the nucleic acid amplification test, allow clinicians to detect and identify organisms more rapidly and accurately and provide guidance to clinicians, who aspire to commence the appropriate antimicrobial therapy as fast as possible and terminate the use of avoidable drugs. The critical care diagnostic market by the end-user is categorized into operation rooms, emergency rooms, and ICU's. The emergency rooms segment in the industry is anticipated to witness the highest growth rate during the forecast period.

Critical Care Diagnostics Market Report Highlights:

  • The Asia Pacific region is expected to grow at the fastest CAGR of 6.9% during the forecast period. The large presence of geriatric population, increasing prevalence of chronic diseases, increase in the number of specialty hospitals in the Asia Pacific region, and improving healthcare services and infrastructures in rural areas are the factors fueling the market growth.
  • The immunoproteins diagnostic test segment is estimated to account for the largest share of the critical care diagnostic market by type. The rise in demand for rapid and accurate preventive healthcare services is one of the major factors driving this market growth.
  • On the basis of end-users, approximately 20% of acute-care patients get admitted into ICU's, whereas nearly 58% get admitted into emergency rooms. The emergency rooms are expected to witness exponential growth with the highest CAGR during the forecast period. The recent rise in the patient demand for ER services is due to its ability to provide initial acute care diagnosis and treatment of critically ill patients.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Critical Care Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Critical Care Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Critical Care Diagnostics: Type Estimates & Trend Analysis

  • 4.1. Critical Care Diagnostics Market: Key Takeaways
  • 4.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Routine and Special Chemistry
    • 4.3.1. Routine and special chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Flow Cytometry
    • 4.4.1. Flow cytometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Hematology
    • 4.5.1. Hematology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Immunoproteins
    • 4.6.1. Immunoproteins market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Microbial and Infectious Disease
    • 4.7.1. Microbial and infectious disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Coagulation Testing
    • 4.8.1. Coagulation testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Critical Care Diagnostics: End Use Estimates & Trend Analysis

  • 5.1. Critical Care Diagnostics Market: Key Takeaways
  • 5.2. Critical Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Operation Room
    • 5.3.1. Operation room market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Intensive Care Unit
    • 5.4.1. Intensive care unit market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Emergency Rooms
    • 5.5.1. Emergency rooms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Critical Care Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Critical Care Diagnostics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Abbott
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Danaher
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. F. Hoffmann-La Roche Ltd
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. BD
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. EKF Diagnostics
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. bioMerieux, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Siemens Healthcare Private Limited
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Chembio Diagnostics, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Bayer AG
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 33 China critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Australia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Thailand critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Latin America critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Mexico critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Argentina critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa critical care diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 UAE critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE critical care diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait critical care diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait critical care diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Critical care diagnostics: Market outlook
  • Fig. 8 Critical care diagnostics: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Critical care diagnostics market driver impact
  • Fig. 14 Critical care diagnostics market restraint impact
  • Fig. 15 Critical care diagnostics market strategic initiatives analysis
  • Fig. 16 Critical care diagnostics market: Type movement analysis
  • Fig. 17 Critical care diagnostics market: Type outlook and key takeaways
  • Fig. 18 Routine and special chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Flow cytometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Hematology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Immunoproteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Microbial and infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Coagulation testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Critical care diagnostics market: End use movement analysis
  • Fig. 26 Critical care diagnostics market: End use outlook and key takeaways
  • Fig. 27 Operation room market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Intensive care unit market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Emergency rooms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Global critical care diagnostics market: Regional movement analysis
  • Fig. 32 Global critical care diagnostics market: Regional outlook and key takeaways
  • Fig. 33 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)